Strides Shasun is currently trading at Rs. 1030.45, up by 22.30 points or 2.21% from its previous closing of Rs. 1008.15 on the BSE.
The scrip opened at Rs. 1022.00 and has touched a high and low of Rs. 1040.00 and Rs. 1015.00 respectively. So far 34,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1259.00 on 03-Feb-2017 and a 52 week low of Rs. 848.50 on 24-May-2017.
Last one week high and low of the scrip stood at Rs. 1040.00 and Rs. 964.70 respectively. The current market cap of the company is Rs. 9,213.00 crore.
The promoters holding in the company stood at 31.12%, while Institutions and Non-Institutions held 49.40% and 19.47% respectively.
Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Omega-3-Acid Ethyl Esters Softgel capsules, a generic version of Lovaza. The US market for the generic Lovaza is approximate $300 million per annum, as per IMS, with five generic players including Par Pharmaceutical (Par), an Endo International Company.
GET FREE INDIAN STOCK MARKET RECOMMENDATIONS WITH GOOD MARKET RESEARCH- LIMITED OFFERS SUBSCRIBE US NOW! Stock Advisory in Indore
No comments:
Post a Comment